Nanosonics Limited (ASX:NAN)
4.030
-0.030 (-0.74%)
Nov 14, 2025, 10:09 AM AEST
Nanosonics Revenue
In the fiscal year ending June 30, 2025, Nanosonics had annual revenue of 198.63M AUD with 16.83% growth. Nanosonics had revenue of 105.03M in the half year ending June 30, 2025, with 24.41% growth.
Revenue
198.63M
Revenue Growth
+16.83%
P/S Ratio
6.21
Revenue / Employee
422.61K
Employees
470
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 198.63M | 28.62M | 16.83% |
| Jun 30, 2024 | 170.01M | 4.02M | 2.42% |
| Jun 30, 2023 | 165.99M | 45.67M | 37.96% |
| Jun 30, 2022 | 120.32M | 17.24M | 16.73% |
| Jun 30, 2021 | 103.08M | 3.03M | 3.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
Nanosonics News
- 8 days ago - Nanosonics Limited (NNCSF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 2 months ago - Nanosonics Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Nanosonics Limited (NNCSF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Billion-dollar medical start-ups say Trump could force a US move - The Australian Financial Review
- 9 months ago - Nanosonics Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 9 months ago - Nanosonics targets 11%-14% revenue growth for FY 2025 driven by North American expansion - Seeking Alpha
- 9 months ago - Nanosonics Limited (NNCSF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Nanosonics Ltd (NNCSF) (H1 2025) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus